The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Open accessAbstract
OBJECTIVE: To report the autoantigens of a new category of treatment-responsive paraneoplastic encephalitis. METHODS: Analysis of clinical features, neuropathological findings, tumors, and serum/cerebrospinal fluid antibodies using rat tissue, neuronal cultures, and HEK293 cells expressing subunits of the N-methyl-D-aspartate receptor (NMDAR). RESULTS: Twelve women (14-44 years) developed prominent psychiatric symptoms, amnesia, seizures, frequent dyskinesias, autonomic dysfunction, and decreased level of consciousness often requiring ventilatory support. All had serum/cerebrospinal fluid antibodies that predominantly immunolabeled the neuropil of hippocampus/forebrain, in particular the cell surface of hippocampal neurons, and reacted with NR2B (and to a lesser extent NR2A) subunits of the NMDAR. NR2B binds glutamate and forms heteromers (NR1/NR2B or NR1/NR2A/NR2B) that are preferentially expressed in the adult hippocampus/forebrain. Expression of functional heteromers (not single subunits) was required for antibody binding. Eleven patients had teratoma of the ovary (six mature) and one a mature teratoma in the mediastinum; five of five tumors examined contained nervous tissue that strongly expressed NR2 subunits and reacted with patients' antibodies. Tumor resection and immunotherapy resulted in improvement or full recovery of eight of nine patients (paralleled by decreased antibody titers); two of three patients without tumor resection died of neurological deterioration. Autopsies showed extensive microgliosis, rare T-cell infiltrates, and neuronal degeneration predominantly involving, but not restricted to, the hippocampus. INTERPRETATION: Antibodies to NR2B- and NR2A-containing heteromers of the NMDAR associate with a severe but treatment-responsive encephalitis. Our findings provide a diagnostic test and suggest a model of autoimmune NMDAR-related encephalitis with broad implications for other immune-mediated disorders of memory, behavior, and cognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preliminary studies suggested the target epitopes were located in extracellular regions of NR1–NR2B NMDA receptors.5”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“We recently identified a disorder, designated anti-NMDA-receptor encephalitis, that associates with antibodies against NR1–NR2 heteromers and results in a characteristic neuropsychiatric syndrome.5”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“The first patients identified were young women with ovarian teratoma who presented with psychosis or memory problems, rapidly progressing to multiple neurological deficits requiring prolonged intensive care support.”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“Serum and CSF were tested for antibodies against the NMDA receptor,5 and considered positive if three immunohistochemical criteria were fulfilled (figure 1).”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“Despite the severity of the disorder, patients often recovered after tumour removal and immunotherapy, suggesting an immune-mediated pathogenesis.”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Gultekin, S. H. (2000) · Brain · doi:10.1093/brain/123.7.1481 · Cited by 1,110
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
Graus, F. (2001) · Brain · doi:10.1093/brain/124.6.1138 · Cited by 891
DeGiorgio, L. A., Konstantinov, K. N., Lee, S. C., Hardin, J., Volpe, B. T., & Diamond, B. (2001) · Nature Medicine · doi:10.1038/nm1101-1189 · Cited by 798
Clinical analysis of anti-Ma2-associated encephalitis
Dalmau, J. O. (2004) · Brain · doi:10.1093/brain/awh203 · Cited by 776
Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections
Cattoretti, G., Pileri, S. A., Parravicini, C., Becker, M. H. G., Poggi, S., Bifulco, C. B., Key, G., D'Amato, L., Sabattini, E., Feudale, E. A. A., et al. (1993) · The Journal of Pathology · doi:10.1002/path.1711710205 · Cited by 721
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma
Vitaliani, R., Mason, W. P., Ances, B. M., Zwerdling, T., Jiang, Z., & Dalmau, J. O. (2005) · Annals of Neurology · doi:10.1002/ana.20614 · Cited by 604
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Ances, B. M., Vitaliani, R., Taylor, R. A., Liebeskind, D. S., Voloschin, A. D., Houghton, D. J., Galetta, S. L., Dichter, M. A., Alavi, A. A., Rosenfeld, M. R., et al. (2005) · Brain · doi:10.1093/brain/awh526 · Cited by 486
Laube, B., Hirai, H., Sturgess, M., Betz, H., & Kuhse, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)81249-0 · Cited by 476
Wenzel, A., Fritschy, J., Möhler, H., & Benke, D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020469.x · Cited by 442
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,000
Pathogenic and physiological autoantibodies in the central nervous system
Gold, M., Pul, R., Bach, J., Stangel, M., & Dodel, R. C. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01128.x · Cited by 47
Tabata, E., Masuda, M., Eriguchi, M., Yokoyama, M., Takahashi, Y., Tanaka, K., Yukitake, M., Horikawa, E., & Hara, H. (2013) · European Neurology · doi:10.1159/000353982 · Cited by 47
Carecchio, M., Cantello, R. M., & Comi, C. (2014) · Journal of Immunology Research · doi:10.1155/2014/239398 · Cited by 46
Würdemann, T. J., Kersten, M., Tokay, T., Guli, X., Kober, M., Rohde, M., Porath, K., Sellmann, T., Bien, C. G., Köhling, R., et al. (2015) · Brain Research · doi:10.1016/j.brainres.2015.12.027 · Cited by 46
Ehrenreich, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00181 · Cited by 46
Autoimmune Encephalitis: A Physician’s Guide to the Clinical Spectrum Diagnosis and Management
Patel, A., Meng, Y., Najjar, A., Lado, F. A., & Najjar, S. (2022) · Brain Sciences · doi:10.3390/brainsci12091130 · Cited by 45
Endres, D., Perlov, E., Stich, O., Rauer, S., Maier, S. J., Waldkircher, Z., Lange, T., Mader, I., Meyer, P. T., & van Elst, L. T. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0552-4 · Cited by 45
EEG Findings May Serve as a Potential Biomarker for Anti–NMDA Receptor Encephalitis
Foff, E. P., Taplinger, D., Suski, J., Lopes, M. B. S., & Quigg, M. (2016) · Clinical EEG and Neuroscience · doi:10.1177/1550059416642660 · Cited by 45
Autoimmune epilepsy: findings on MRI and FDG-PET
Guerin, J. B., Watson, R. E., Carr, C. M., Liebo, G. B., & Kotsenas, A. L. (2018) · British Journal of Radiology · doi:10.1259/bjr.20170869 · Cited by 45
Bien, C. G. (2013) · Epilepsia · doi:10.1111/epi.12184 · Cited by 44
van Coevorden‐Hameete, M. H., Titulaer, M. J., Schreurs, M. W. J., de Graaff, E., Smitt, P. A. E. S., & Hoogenraad, C. C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00037 · Cited by 44
Current trends in autoimmunity and the nervous system
Selmi, C. F., Barin, J. G., & Rose, N. R. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.08.005 · Cited by 47
Zeng, C., Chen, L., Chen, B., Cai, Y., Li, P., Yan, L., & Zeng, D. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy137 · Cited by 44
Cell-Free Mitochondrial DNA in the CSF: A Potential Prognostic Biomarker of Anti-NMDAR Encephalitis
Yu, P., Zheng, D., Zhang, X., Pan, S., Ji, T., Zhang, J., Shen, H., & Wang, H.-H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00103 · Cited by 44
Characterising seizures in anti-NMDA-receptor encephalitis with dynamic causal modelling
Cooray, G., Sengupta, B., Douglas, P. K., Englund, M., Wickström, R., & Friston, K. J. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.05.064 · Cited by 43
Manto, M. U., Dalmau, J. O., Didelot, A., Rogemond, V., & Honnorat, J. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5674-5 · Cited by 43
Autoantibodies and neurodegeneration in multiple sclerosis
Vyshkina, T., & Kálmán, B. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.53 · Cited by 44
Nazif, T. M., Vazquez, J., Honig, L. S., & Dizon, J. M. (2012) · EP Europace · doi:10.1093/europace/eus014 · Cited by 43
Biomarkers of inflammatory and auto-immune central nervous system disorders
Dale, R. C., & Brilot, F. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283402b71 · Cited by 43
Tachibana, N., Shirakawa, T., Ishii, K., Takahashi, Y., Tanaka, K., Arima, K., Yoshida, T., & Ikeda, S. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.4069 · Cited by 43
Autoimmune-mediated encephalitis
Demaerel, P., Dessel, W. V., Paesschen, W. V., Vandenberghe, R. R., Laere, K. V., & Linn, J. (2011) · Neuroradiology · doi:10.1007/s00234-010-0832-0 · Cited by 42
Pitfalls in clinical diagnosis of anti-NMDA receptor encephalitis
Kaneko, A., Kaneko, J., Tominaga, N., Kanazawa, N., Hattori, K., Ugawa, Y., Moriya, A., Kuzume, D., Ishima, D., Kitamura, E., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8749-3 · Cited by 45
Autoimmune encephalitis and psychiatric disorders
Honnorat, J., & Plazat, L.-O. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2017.11.004 · Cited by 43
Impaired Glycine Receptor Trafficking in Neurological Diseases
Schaefer, N., Roemer, V., Janzen, D., & Villmann, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00291 · Cited by 43
Immunity, Ion Channels and Epilepsy
Chen, T., Lai, M., Huang, H.-Y. I., Wu, S., & Huang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126446 · Cited by 46
Paraneoplastic Neurologic Disorders
Gilligan, M., McGuigan, C., & McKeon, A. B. (2023) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-023-01250-w · Cited by 47
de Bruijn, M. A. A. M., Leypoldt, F., Dalmau, J. O., Lee, S., Honnorat, J., Clardy, S. L., Irani, S. R., Easton, A., Kunchok, A. C., & Titulaer, M. J. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00650-1 · Cited by 44
Autoimmune NMDA receptor encephalitis
Lázár‐Molnár, E., & Tebo, A. E. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.010 · Cited by 42
Autoimmune causes of encephalitis syndrome in Thailand: prospective study of 103 patients
Saraya, A. W., Mahavihakanont, A., Shuangshoti, S., Sittidetboripat, N., Deesudchit, T., Callahan, M. V., Wacharapluesadee, S., Wilde, H., & Hemachudha, T. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-150 · Cited by 41
Electroconvulsive Therapy in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Coffey, M. J., & Cooper, J. J. (2016) · Journal of Ect · doi:10.1097/yct.0000000000000334 · Cited by 42
Inflammation in Tic Disorders and Obsessive-Compulsive Disorder: Are PANS and PANDAS a Path Forward?
Gilbert, D. L. (2019) · Journal of Child Neurology · doi:10.1177/0883073819848635 · Cited by 43
Autoimmune Encephalitis in Children: An Update
Garg, D., Mohammad, S. S., & Sharma, S. (2020) · Indian Pediatrics · doi:10.1007/s13312-020-1896-5 · Cited by 43
Serafini, A., Lukas, R. V., VanHaerents, S. A., Warnke, P. C., Tao, J. X., Rose, S., & Wu, S. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.04.046 · Cited by 42
Lim, M. J., Hacohen, Y., & Vincent, A. C. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2015.03.011 · Cited by 42
Structural and functional mechanisms of anti-NMDAR autoimmune encephalitis
Michalski, K. R., Abdulla, T., Kleeman, S., Schmidl, L., Gómez, R. J., Simorowski, N., Vallese, F., Prüß, H., Heckmann, M., Geis, C., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01386-4 · Cited by 43
Anti-NMDA Receptor Encephalitis
Ryan, S. A., Costello, D. J., Cassidy, E., BROWN, G., Harrington, H. J., & Markx, S. (2013) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000428562.86705.cd · Cited by 42
Kiani, R., Lawden, M., Eames, P. J., Critchley, P., Bhaumik, S., Odedra, S., & Gumber, R. (2015) · BJPsych Bulletin · doi:10.1192/pb.bp.112.041954 · Cited by 41
Kruse, J. L., Jeffrey, J. K., Davis, M. C., Dearlove, J., IsHak, W. W., & Brooks, J. O. (2014) · Annals of Clinical Psychiatry · doi:10.1177/104012371402600205 · Cited by 42
Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong
Ho, A. C.-C., Chan, H. S., Chan, E. S. Y., Wong, S. S.-N., Fung, S., Cherk, S. W. W., Fung, E. L.-W., Ma, K.-H., Tsui, K.-W., Yau, E. K., et al. (2018) · Brain and Development · doi:10.1016/j.braindev.2018.02.005 · Cited by 41
Differential diagnosis with other rapid progressive dementias
Geschwind, M. D., & Murray, K. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00020-9 · Cited by 43
A systematic review of Gamma-aminobutyric Acid Receptor Type B autoimmunity
McKay, J. H., Dimberg, E. L., & Lopez-Chiriboga, A. S. (2018) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2018.0005 · Cited by 42
Long‐term cognitive and neuropsychiatric outcomes in patients with anti‐NMDAR encephalitis
Liu, X., Zhang, L., Chen, C., Gong, X., Lin, J., An, D., Zhou, D., & Hong, Z. (2019) · Acta Neurologica Scandinavica · doi:10.1111/ane.13160 · Cited by 40
Clinically based score predicting cryptogenic NORSE at the early stage of status epilepticus
Yanagida, A., Kanazawa, N., Kaneko, J., Kaneko, A., Iwase, R., Suga, H., Nonoda, Y., Onozawa, Y., Kitamura, E., Nishiyama, K., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000849 · Cited by 41
Autoimmune autonomic ganglionopathy with late-onset encephalopathy
Baker, S. K., Morillo, C. A., & Vernino, S. A. (2008) · Autonomic Neuroscience · doi:10.1016/j.autneu.2008.10.016 · Cited by 42
Case 26-2008: A 26-Year-Old Woman with Headache and Behavioral Changes
Sabin, T. D., Jednacz, J. A., & Staats, P. N. (2008) · New England Journal of Medicine · doi:10.1056/nejmcpc0804644 · Cited by 41
Segal, Y., Soltys, J. N., Clarkson, B. D. S., Howe, C. L., Irani, S. R., & Pittock, S. J. (2025) · Neuron · doi:10.1016/j.neuron.2024.12.006 · Cited by 40
What should you know about limbic encephalitis?
Machado, S., Pinto, A. N., & Irani, S. R. (2012) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2012001000012 · Cited by 40
Update on Paraneoplastic Neurologic Disorders
Rosenfeld, M. R., & Dalmau, J. O. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-0001 · Cited by 40
Li, Y., Viscidi, R. P., Kannan, G., McFarland, R., Pletnikov, M. V., Severance, E. G., Yolken, R. H., & Xiao, J. (2018) · Infection and Immunity · doi:10.1128/iai.00398-18 · Cited by 42
Anti-N-Methyl d-Aspartate Receptor Encephalitis and Electroconvulsive Therapy
Tanguturi, Y. C., Cundiff, A. W., & Fuchs, C. (2018) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2018.07.005 · Cited by 41
18F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis
Deuschl, C., Rüber, T., Ernst, L., Fendler, W. P., Kirchner, J., Mönninghoff, C., Herrmann, K., Quesada, C. M., Forsting, M., Elger, C. E., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227906 · Cited by 40
Liu, J., Liu, L., Kang, W., Peng, G., Yu, D., Ma, Q., Li, Y., Zhao, Y., Li, L., Dai, F., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.582296 · Cited by 40
Update on paraneoplastic neurological syndromes
Didelot, A., & Honnorat, J. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283306647 · Cited by 40
Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies
Alexopoulos, H., Kosmidis, M. L., Dalmau, J. O., & Dalakas, M. C. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5982-4 · Cited by 39
Clinical analysis of paraneoplastic encephalitis associated with ovarian teratoma
Tonomura, Y., Kataoka, H., Hara, Y., Takamure, M., Naba, I., Kitauti, T., Saito, K., & Ueno, S. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9372-9 · Cited by 40
ACR Appropriateness Criteria® Imaging of Mediastinal Masses
Ackman, J. B., Chung, J. H., Walker, C. M., Bang, T. J., Carter, B. W., Hobbs, S., Kandathil, A., Lanuti, M. D., Madan, R., Moore, W. H., et al. (2021) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2021.01.007 · Cited by 39
Acute psychiatric illness in a young woman: an unusual form of encephalitis
Parratt, K. L., Allan, M., Lewis, S. J. G., Dalmau, J. O., Halmagyi, G. M., & Spies, J. M. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02787.x · Cited by 37
Autoimmunity, neuroinflammation, pathogen load: A decisive crosstalk in neuropsychiatric SLE
Jeltsch‐David, H., & Muller, S. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.04.005 · Cited by 40
Iemura, Y., Yamada, Y., Hirata, M., Kataoka, T. R., Minamiguchi, S., & Haga, H. (2018) · Pathology International · doi:10.1111/pin.12732 · Cited by 39
Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome
Panzer, J. A., Anand, R., Dalmau, J. O., & Lynch, D. R. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.07.007 · Cited by 39
Kaplan, P. W., Rossetti, A. O., Kaplan, E. H., & Wieser, H. G. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.11.029 · Cited by 38
Vincent, A. C. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9401-x · Cited by 38
Anti-NMDA receptor encephalitis presenting with total insomnia — A case report
Marques, I. B., Teotónio, R., Cunha, C., Bento, C., & Sales, F. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.10.034 · Cited by 38
Goenka, A., Jain, V., Nariai, H., Spiro, A. J., & Steinschneider, M. (2017) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2017.03.010 · Cited by 38
Neurobiology of autoimmune encephalitis
Fukata, M., Yokoi, N., & Fukata, Y. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.07.012 · Cited by 38
Yu, P., Liu, B., Pei, S., Zheng, D., Wang, Z., Ji, T., Pan, S., Shen, H., & Wang, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00905 · Cited by 38
Li, J., Gu, Y., An, H., Zhou, Z., Dong, Z., Wang, Z., Wen, Z., Shen, H., Wang, Q., & Wang, H. (2019) · Brain and Behavior · doi:10.1002/brb3.1354 · Cited by 38
Understanding Childhood Neuroimmune Diseases of the Central Nervous System
Matricardi, S., Farello, G., Savasta, S., & Verrotti, A. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00511 · Cited by 40
Zhang, N., Xing, M., Wang, Y., Liang, H., Yang, Z. R., Shi, F., & Cheng, Y. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1375-2 · Cited by 38
Psychiatric phenomena as initial manifestation of encephalitis by anti‐NMDAR antibodies
Maat, P., de Graaff, E., van Beveren, N. J. M., Hulsenboom, E., Verdijk, R. M., Koorengevel, K. M., VanDuijn, M. M., Hooijkaas, H., Hoogenraad, C. C., & Smitt, P. A. E. S. (2012) · Acta Neuropsychiatrica · doi:10.1111/acn.12013 · Cited by 37
Autoimmunity in psychotic disorders. Where we stand, challenges and opportunities
Mané-Damas, M., Hoffmann, C., Zong, S., Tan, A., Molenaar, P. C., Losen, M. H., & Martínez‐Martínez, P. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102348 · Cited by 38
Graus, F., & Saiz, A. (2008) · Neurology · doi:10.1212/01.wnl.0000299189.43164.96 · Cited by 38
Ma, Y., Wang, J., Guo, S., Meng, Z., Ren, Y. D., Xie, Y., & Wang, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1064007 · Cited by 38
Long term rehabilitation management and outcome of anti-NMDA receptor encephalitis: Case reports
Bach, L. J. (2014) · Neurorehabilitation · doi:10.3233/nre-141176 · Cited by 39
Immunotherapeutics for Autoimmune Encephalopathies and Dementias
McKeon, A. B. (2013) · Current Treatment Options in Neurology · doi:10.1007/s11940-013-0251-8 · Cited by 37
Wilson, M. R. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328360dd2b · Cited by 37
Anti– N -Methyl- D -Aspartate (NMDA) Receptor Encephalitis
Scott, O., Richer, L. P., Forbes, K., Sonnenberg, L. K., Currie, A., Eliyashevska, M., & Goez, H. (2013) · Journal of Child Neurology · doi:10.1177/0883073813501875 · Cited by 39
Initial serum thyroid peroxidase antibodies and long-term outcomes in SREAT
Litmeier, S., Prüß, H., Witsch, E., & Witsch, J. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12556 · Cited by 37
Clinical analysis on anti-N-methyl-D-aspartate receptor encephalitis cases: Chinese experience.
Huang, X., Fan, C., Wu, J., Ye, J., Zhan, S., Song, H., Liu, A., Su, Y., & Jia, J. (2015) · PubMed Central · Cited by 37
Wang, B., Wang, C.-J., Zeng, Z., Yang, Y., & Guo, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.04.007 · Cited by 38
Sachs, J. R., Zapadka, M. E., Popli, G., & Burdette, J. H. (2017) · Radiology Case Reports · doi:10.1016/j.radcr.2017.06.004 · Cited by 37
Bortezomib in anti-N-Methyl-d-Aspartate-Receptor (NMDA-R) encephalitis: A systematic review
Dinoto, A., Cheli, M., Bratina, A., Sartori, A., & Manganotti, P. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577586 · Cited by 37
Ding, J., Li, X., & Tian, Z. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.711376 · Cited by 37
Autoimmune and Paraneoplastic Chorea: A Review of the Literature
Kyle, K., Bordelon, Y. M., Venna, N., & Linnoila, J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.829076 · Cited by 37
Busse, S., Brix, B., Kunschmann, R., Bogerts, B., Stoecker, W., & Busse, M. (2014) · Neuroscience Research · doi:10.1016/j.neures.2014.06.002 · Cited by 37
Anti-NMDA receptor encephalitis with the initial presentation of psychotic mania
Kuo, Y. L., Tsai, H. F., Lai, M. C., Lin, C. H., & Yang, Y. K. (2012) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.10.006 · Cited by 36
The growing spectrum of antibody-associated inflammatory brain diseases in children
Bigi, S., Hladio, M., Twilt, M., Dalmau, J. O., & Benseler, S. M. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000092 · Cited by 37
Autoantikörper-assoziierte schizophreniforme Psychosen: Pathophysiologie, Diagnostik und Therapie
van Elst, L. T., Bechter, K., Prüß, H., Hasan, A., Steiner, J. H., Leypoldt, F., & Endres, D. (2019) · Der Nervenarzt · doi:10.1007/s00115-019-0735-1 · Cited by 36
The Discovery of Autoimmune Nodopathies and the Impact of IgG4 Antibodies in Autoimmune Neurology
Querol, L., & Dalakas, M. C. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200365 · Cited by 36
The Rehabilitation of Children with Anti–N-methyl-D-aspartate–Receptor Encephalitis
Houtrow, A. J., Bhandal, M., Pratini, N. R., Davidson, L. T., & Neufeld, J. A. (2012) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e3182465da6 · Cited by 37
Varley, J. A., Vincent, A. C., & Irani, S. R. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7600-8 · Cited by 36
Reversible paraneoplastic encephalitis in three patients with ovarian neoplasms
Tanyi, J. L., Marsh, E. B., Dalmau, J. O., & Chu, C. (2012) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2011.01365.x · Cited by 37
Autoimmune Channelopathies of the Nervous System
Kleopa, K. A. (2011) · Current Neuropharmacology · doi:10.2174/157015911796557966 · Cited by 36
Brenton, J. N., Kim, J. P., & Schwartz, R. H. (2016) · Journal of Child Neurology · doi:10.1177/0883073816643406 · Cited by 36
Initial clinical presentation of young children with N-methyl- d -aspartate receptor encephalitis
Favier, M., Joubert, B., Picard, G., Rogemond, V., Thomas, L., Rheims, S., Bailhache, M., Villega, F., Pedespan, J., Berzero, G., et al. (2017) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2017.12.014 · Cited by 36
Yang, S., Zhang, X., Mei, F., Tang, J., Liao, H., & Tan, L. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6329 · Cited by 36
A Metabolic Brain Pattern Associated With Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Kerik-Rotenberg, N. E., Díaz-Meneses, I. E., Hernández-Ramírez, R., Muñoz-Casillas, R., Reynoso-Mejía, C. A., Flores-Rivera, J. D. J., Espínola-Nadurille, M., Ramírez‐Bermúdez, J., & Aguilar, C. (2019) · Psychosomatics · doi:10.1016/j.psym.2019.08.007 · Cited by 35
The diverse and complex modes of action of anti-NMDA receptor autoantibodies
Wollmuth, L. P., Chan, K., & Groc, L. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108624 · Cited by 41
Contemporary advances in anti-NMDAR antibody (Ab)-mediated encephalitis
Seery, N., Butzkueven, H., O'Brien, T. J., & Monif, M. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103057 · Cited by 39
Seillier, C., Lesept, F., Toutirais, O., Potzeha, F., Blanc, M., & Vivien, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810336 · Cited by 47
Metadata
- Authors
- Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., Mason, W., Sansing, L. H., Dichter, M. A., Rosenfeld, M. R., & Lynch, D. R.
- Affiliations
- University of Pennsylvania (US)
- Augusta University (US)
- Yale University (US)
- Jichi Medical University (JP)
- Tokyo Metropolitan Neurological Hospital (JP)
- Children's Hospital of Pittsburgh (US)
- Princess Margaret Cancer Centre (CA)
- Corresponding author
- Dalmau, Josep
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 61
- Issue
- 1
- Pages
- 25-36
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC2430743
- OpenAlex
- W2114398221
- Cited by
- 2,492
- References
- 37
- Citations by year
- 2026: 105 · 2025: 122 · 2024: 142 · 2023: 135 · 2022: 168 · 2021: 190 · 2020: 158 · 2019: 179 · 2018: 128 · 2017: 152 · 2016: 158 · 2015: 145 · 2014: 129 · 2013: 143 · 2012: 113
- FWCI
- 47.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA089054, R01CA107192)
- National Institute of Neurological Disorders and Stroke (R01NS045986)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Clinical Neurology › Myasthenia Gravis and Thymoma
- Keywords
- paraneoplastic encephalitis, anti-NMDA receptor encephalitis, ovarian teratoma, NMDA receptor subunits, NR2B, NR2A, autoantibodies, hippocampal neurons, autoimmune encephalitis, tumor resection, immunotherapy, microglial activation, neurodegeneration, psychiatric symptoms, amnesia, seizures
- MeSH terms
- Adolescent, Adult, Animals, Antibodies, Dissection, Encephalitis, Female, Humans, Immunohistochemistry, Immunosuppressive Agents, Magnetic Resonance Imaging, Male, Neurons, Ovarian Neoplasms, Teratoma, Transfection, Gene Expression Regulation, Neoplastic, Receptors, N-Methyl-D-Aspartate, Treatment Outcome, Rats, Wistar, Protein Subunits, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review